BAL PHARMA LTD. SHARE PRICE [LIVE]
BSE: INE083D01012 NSE: BALPHARMA SECTOR: Pharma
Open: | |
High: | |
Low: |
MKT Cap: | |
52-wk High: | |
52-wk Low: |
Prev close: | |
P/E: | |
Div yield: |
Fundamental analysis
What is not working for the company?
What is working for the company?
Name | Mar 21 | Dec 20 |
---|
Similar Stocks
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made LUMPSUM investment of ₹ 1,00,000
in BAL PHARMA LTD.
Months ago
My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %
BALPHARMA News
- ANUP MALLEABLE LTD.
- GAYATRI PROJECTS LTD.
- MARATHON NXTGEN REALT LIMITED
- IGARASHI MOTORS INDIA LTD.
- ASIAN STAR CO.LTD.
- DEEP POLYMERS LIMITED
- KAY POWER AND PAPER LIMITED
- MTAR TECHNOLOGIES LIMITED
- SOUTHERN GAS LIMITED
- EQUITAS SMALL FINANCE BANK LIMITED
- CAMLIN FINE SCIENCES LTD.
- ASSAM ENTRADE LIMITED
- PCBL LIMITED
- MUKESH BABU FINANCIAL SERVICES LTD.
- NARMADA AGROBASE LIMITED
- JAY USHIN LTD.
- FUTURE SUPPLY CHAIN SOLUTIONS LIMITED
- CHEMIESYNTH (VAPI) LTD
- TRANSOCEANIC PROPERTIES LIMITED
- APM INDUSTRIES LTD.
Frequently Asked Questions
What is the Share price of BAL PHARMA LTD. (BALPHARMA)?
Can I buy BAL PHARMA LTD. (BALPHARMA) shares?
How do I buy BAL PHARMA LTD. (BALPHARMA) from Angel One?
- Direct investment: You can buy BAL PHARMA LTD. (BALPHARMA) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to BAL PHARMA LTD. (BALPHARMA) shares.
In which sector do BAL PHARMA LTD. (BALPHARMA) belong?
About BALPHARMA
Today's live share price for BAL PHARMA LTD. is NSE: ₹ 99.15, BSE: ₹ 99.40 with a current market capitalization of .
Bal Pharma (BPL), a member of the Mcro Laboratories group, was incorporated as a private limited company in May '87. In Mar.'90, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations. BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc. The company promotes its products through the common sales force of the group but proposes to induct its own soon. It came out with a public issue in Feb.'95 for manufacture of bulk drugs and expansion of pharmaceutical formulations. During 1997-98, the formalities of takeover of the unit from Lakme Limited have been completed and effective from 23rd July, 1997 the unit has become a division of Bal Pharma Limited. The company's product range has been expanded with the introduction of AZIWIN, CAFIMOL & CORTIDERM. The company has added further product range Zanovid, Aziwin, Dry Syrup, Meloxi, Ocium - M, Progit - MPS in its ethical division during 1999-2000. As part of the expansion of the product range, the company has introduced Cardiac Specialities Products. To market these products, a new division named "SERVETUS" has started functioning during 2001. New products like Amiloride,Benzydamine and Ebastine were rolled into the market during 2002.
Read more